Board summary
Key figures
36,294
Registered population
59.2% aged 18–64
20.0%
Aged 65+
ICB 19.9% · England 17.9%
6.6%
Ethnic minority (non-White)
2.7% Asian · England 9.6%
38.0%
In IMD quintile 1
ICB 17.1% · England 21.0%
~12,751
Core20 residents (est.)
Resident basis; registered basis ~13,875 · see page 3
6,028
Hypertension register
+6.19% in 3 yrs · England +5.60%
399
SMI register
31.3% of Dover's
1,071
COPD register
Reviews -32.70% in 3 yrs
Forecast to 2030
7,116
Hypertension patients, 2030
+1,088 on today
65.1%
QRISK ≥20% on statins, 2030
+0.99pp over 3 yrs
5.8%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Respiratory annual reviews lag behind England.
COPD reviews reached 49.5% after falling 32.7% (England +2.8%), and asthma reviews reached 59.0% (about 920 unreviewed), which may reflect recall gaps.
Phone access varies widely across practices.
Easy phone contact spans 36.4 pp from 33.2% at Pencester Surgery (62.0% Core20) to 69.6% at Lydden Surgery, which could reflect demand pressures.
Two-year childhood immunisations exceed the 95.0% target.
At 24 months, 6-in-1 coverage is 97.4% (England 92.2%) and first-dose MMR is 96.1% (England 88.3%), both exceeding the 95.0% target.
Population, age and ethnicity
Registered patients aged 65+ reach 20.0%, above England but below Dover
Across 36,294 registered patients, 20.0% (7,266) are aged 65+, trailing Dover (24.2%) but exceeding NHS Kent and Medway ICB (19.9%) and England (17.9%). Children aged 0-17 comprise 20.7% (7,525), above Dover (19.0%), in line with the ICB (20.7%), and above England (19.6%). Census estimates of usual residents indicate 93.4% are White, compared to 94.9% in Dover, 88.6% in the ICB, and 81.1% nationally (non-White ethnic minority share 6.6%). Projected list growth to 2030 is 4.3% via an unverified methodology (Dover 5.3%, ICB 6.0%, England 2.3%).
Age profile
65+: ICB 19.9%, England 17.9%
Ethnicity
Older people · falls rows are Dover local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Dover LA) | 1,557 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 80.6% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 56.1% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Dover LA) | 886 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Dover LA) | 25.9 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation reaches 38.0% across the PCN and varies widely between practices
Core20 deprivation covers 38.0% of registered patients, above Dover (22.9%), NHS Kent and Medway ICB (17.1%), and England (21.0%), alongside an estimated 12,751 residents in deciles 1 and 2. Deprivation is sharply polarised across practices, spanning 62.0 pp from Pencester Surgery (61.97%, an estimated 7,052 patients) and White Cliffs Medical Centre (47.73%, 4,661 patients) to Lydden Surgery (0.0%). Practice-level Core20 estimates sum to 13,875 patients, reflecting differing population bases from the resident count. This concentration suggests outreach capacity could be prioritised at the highest-volume practices.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
399
SMI register
1.09% recorded prevalence
289
Learning disability register
0.79% recorded prevalence
36
Care homes, 742 beds
In the PCN catchment
10.3%
Provide unpaid care
Dover, Census 2021
Recorded registers include 399 patients with severe mental illness (1.1%; Dover 1.1%, ICB 0.9%, England 1.0%) and 289 with learning disabilities (0.8%; Dover 0.8%, ICB 0.6%, England 0.6%). The PCN catchment contains 36 care homes with 742 beds, though resident registration is unconfirmed. With both inclusion registers exceeding England rates, physical-health reviews and coordinated care-home outreach represent key workloads to protect.
Severe mental illness: physical health checks
SMI blood pressure check completion is 71.3% (England 83.4%), falling 6.0 pp over 2023 to 2025 (England +4.4 pp). Recorded BMI on the SMI register is 70.8% (England 82.1%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
6,028
Hypertension register
+6.19%
Register growth, 3 yrs
Dover +6.06% · England +5.60%
−0.18pp
BP control, under 80
≤140/90 · −1.58pp aged 80+
+1,088
More patients by 2030
Forecast 7,116 (18.62%)
Hypertension case-finding and control
Hypertension register prevalence is 16.5%, below Dover (18.3%) but above England (15.2%) and NHS Kent and Medway ICB (16.2%). However, clinical monitoring and control lag across benchmarks: recent blood pressure checks stand at 85.2% after falling 4.4 pp over 2023 to 2025 (England +3.1 pp), and treatment to target is 65.4% (England 70.3%, Dover 69.1%). For patients aged under 80, control to <= 140/90 mmHg is 63.7% against 67.8% in England, dropping to 58.5% at Pencester Surgery. Crude prevalence is not age-adjusted.
Lipids and statins
Lipid therapy for patients with QRISK 20% or more is 63.1% (England 63.6%), rising 1.0 pp over 2023 to 2025 (England +3.8 pp). Statin uptake in diabetes exceeds England at 74.7% for primary prevention and 85.4% for secondary prevention.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 64,993 | £1.60 | £1.90 | £1.86 | £103,989 |
| Cardiovascular (all), 2025 | 86,693 | £5.06 | £3.57 | £3.33 | £438,667 |
For lipid-regulating drugs in 2026, 64,993 items were prescribed at £1.60 per item, below England (£1.86), NHS Kent and Medway ICB (£1.90), and Dover (£2.27). The PCN spends £16,898 less than at England's unit cost across these 64,993 items. This unit-cost indicator does not evaluate formulary efficiency.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−7.92%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+2.31%
Asthma prevalence, PCN 3-yr % change
COPD prevalence is 2.9% (1,071 patients; England 1.9%), up +13.5% over 2023 to 2025 (England +2.6%). However, COPD reviews dropped to 49.5% (England 76.4%), falling 32.7% (England +2.8%). Asthma prevalence is 6.5% (2,242 patients; England 6.6%), but reviews fell 7.9% to 59.0% (England 65.7%, England +4.4%), leaving about 920 unreviewed patients. Slower review completion may indicate review capacity constraints, which a practice audit could test.
Cancer register and children's immunisation
Cancer prevalence is 4.7% (1,697 patients; England 3.8%). In COVER Q1 2025/26 childhood immunisations, 24-month courses exceed the 95.0% target (6-in-1 97.4%, MMR dose 1 96.1%). However, age-5 boosters trail the target at 92.6% for MMR dose 2 and 90.4% for 4-in-1 (England 82.8% and 80.9%). Denominators are 76 to 94 children, where small cohort sizes limit comparisons.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.6%
Kent and Medway ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,630
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Kent and Medway ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 82.1% | 85.4% | 23% | 1,509 |
| Prostate | 54.4% | 53.2% | 37% | 1,435 |
| Lung | 29.4% | 33.8% | 21% | 1,109 |
| Bowel | 48.2% | 47.0% | 29% | 1,013 |
| Skin cancer | 87.5% | 87.8% | 23% | 562 |
In 2022, NHS Kent and Medway ICB recorded 55.6% of staged cancers diagnosed at stage 1 or 2 (England 55.3%), with a distance of -19.4 pp to the 75.0% national ambition by 2028, and 63.6% having a known stage. Reaching 75.0% required 1,627 extra early-stage cases a year, following an ICB early-stage share change of +2.2 pp from 2013 to 2022. Staging reflects system data rather than PCN delivery. For the PCN, cervical screening (25–49 years) is 64.9% (ICB 69.9%, England 66.8%), spanning 54.4% at Pencester Surgery, 64.3% at White Cliffs Medical Centre, 73.3% at Aylesham Medical Practice, and 76.2% at Lydden Surgery.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026, East Kent Hospitals University NHS Foundation Trust achieved 70.0% on the 62-day cancer standard (85.0% standard), against 87.4% at Maidstone and Tunbridge Wells NHS Trust, 67.0% at East Sussex Healthcare NHS Trust, 75.9% for NHS Kent and Medway Integrated Care Board, and 71.2% in England. On the 28-day faster diagnosis standard (75.0% standard), East Kent reached 71.3% (Maidstone and Tunbridge Wells NHS Trust 81.8%, East Sussex Healthcare NHS Trust 84.2%, England 79.3%). Trust six-week diagnostic waits were 47.6% for MRI and 37.4% for CT. These figures describe trust activity, not PCN referrals.
| Pathways within standard (%) | East Kent | East Sussex Healthcare | Maidstone and Tunbridge Wells | Kent and Medway ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.28 | 84.20 | 81.78 | 76.78 | 79.32 |
| 31-day treatment (96%) | 96.67 | 98.19 | 98.35 | 95.84 | 92.50 |
| 62-day referral to treatment (85%) | 70.01 | 67.04 | 87.43 | 75.93 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Kent | East Sussex Healthcare | Maidstone and Tunbridge Wells | England |
|---|---|---|---|---|
| MRI | 47.58 | 6.48 | 0.92 | 21.40 |
| CT | 37.45 | 0.48 | 0.51 | 9.92 |
| Echocardiography | 14.17 | 21.94 | 2.57 | 28.48 |
| Colonoscopy | 9.58 | 0.74 | 19.80 | 30.83 |
| Gastroscopy | 22.16 | 0.31 | 24.03 | 29.02 |
| All 15 DM01 tests | 48.38 | 5.27 | 6.42 | 23.14 |
| Community services activity | Kent residents | Kent and Medway ICB |
|---|---|---|
| Care contacts | 210,170 | 254,055 |
| Referrals | 59,360 | 68,085 |
| Patients with a contact | 60,605 | 72,060 |
Community services (residents of Kent), Jun 2026 (provisional). In the June 2026 community services dataset, adults aged 65 and over accounted for 65.8% of all community contacts among Dover borough residents (138,250 of 210,170 contacts). Within Total Health Excellence East PCN, 20.0% of registered patients (7,266 people) are aged 65+, compared to 17.9% across England. These community activity metrics represent resident borough use rather than PCN-specific service delivery.
Practice variation and patient experience
Phone access spans 36.4 pp across practices, alongside a 28.7 pp experience variation
In 2025/26, QOF vaccination and immunisation achievement spans 61.1 pp across captured practices: Pencester Surgery achieved 35.1%, whereas Lydden Surgery achieved 96.2% (England: 55.2%). For overall QOF achievement, White Cliffs Medical Centre reached 87.8%, while Lydden Surgery reached 99.6% (England: 92.5%). Across all domains, the personalised care adjustment rate at Pencester Surgery is 18.0%.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Lydden Surgery | 119 | 0.0 | 69.6% | 72.8% | 87.8% |
| White Cliffs | 99 | 47.7 | 50.4% | 60.0% | 69.6% |
| Aylesham Medical | 102 | 24.2 | 45.7% | 68.0% | 63.0% |
| Pencester Surgery | 111 | 62.0 | 33.2% | 51.3% | 59.1% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Eighteen of 25 tracked measures trail England over three years, led by falling reviews
Eighteen of 25 tracked measures trail England's three-year change. The widest lags are in annual disease reviews: heart failure reviews fell 30.9% (England +8.7%), COPD reviews fell 32.7% (England +2.8%), and asthma reviews fell 7.9% (England +4.4%). Physical health checks on the mental health register also declined, with blood pressure recording falling 6.0 pp (England +4.4 pp). In contrast, cervical screening rose 0.3% (England -1.0%). These declines could reflect review capacity constraints or recording changes across practices, which targeted audits could verify.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
COPD reviews
Asthma reviews
BP check (SMI)
Diabetes HbA1c control
Cervical screening
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Dover | Asset | PCN | Dover |
|---|---|---|---|---|---|
| Care homes (catchment) | 36 (742 beds) | n/a | Schools (catchment) | 69 | n/a |
| Children's centres | 6 | 7 | Places of worship | 62 | 106 |
| Libraries | 2 | 5 | Food banks (VCS) | 2 | 2 |
| Homelessness support (VCS) | 1 | 1 | Day centres (VCS) | 3 | 4 |
| Carers support groups (VCS) | 3 | 4 | Primary schools (LA maintained) | 16 | 19 |
| Primary academies | 11 | 21 | Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured respiratory annual review recall
Asthma review completion is 59.0% (England 65.7%, Dover 62.0%), changing -7.9% (-5.1 pp) over 2023 to 2025 and leaving 919 of 2,242 patients unreviewed; COPD reviews fell 32.7% to 49.5% (England 76.4%). For discussion: practices could run single-template respiratory recall and inhaler checks, prioritising high-Core20 lists. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Hypertension BP control and case-finding
Among 6,028 hypertension patients (16.5% vs Dover 18.3%, England 15.2%; gap range -501 to +630), recent BP readings fell 4.4 pp to 85.2% (England 90.0%) and target control is 65.4% (England 70.3%). For discussion: practices could run pharmacist-led BP titration clinics and opportunistic checks in high-Core20 practices. Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 3
Combined SMI physical health check clinics
Across 399 SMI register patients, 12-month BP checks are 71.3% (England 83.4%, Dover 79.6%; -6.0 pp over 2023 to 2025 vs England +4.4 pp), BMI recording is 70.8% (England 82.1%), and alcohol recording is 66.2% (England 81.8%). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Targeted Core20 link worker outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check audit (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension control recall audit (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall outreach (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Telephony and triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Structured respiratory annual review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD register | Core20PLUS5 respiratory | PCN |
| Option 2 · Hypertension BP control and case-finding (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP reading | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
| Option 3 · Combined SMI physical health check clinics (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs) | MHIS · From Harm to Hope | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
